Surgeons at Rambam Eye Institute have achieved a groundbreaking milestone in ophthalmologic medicine by restoring sight to a legally blind patient using a fully 3D printed corneal implant derived entirely from cultured human cells. This innovative procedure marks the first successful transplantation of a corneal implant that does not depend on traditional donor tissue. The implications of this breakthrough could greatly alter the landscape of corneal transplants, offering hope to millions affected by severe vision impairment.

A breakthrough that turns one donor cornea into hundreds

The journey of this revolutionary procedure began with a healthy cornea sourced from a deceased donor. Researchers utilized advanced techniques in regenerative medicine to multiply the corneal cells in laboratory settings. Specifically, these cultured cells were then used to create approximately 300 transparent implants using Precise Bio’s innovative 3D printing platform. This method effectively replicates the natural structure and functionality of a human cornea, ensuring that the implants provide the necessary clarity, strength, and long-term usability.

This development is particularly noteworthy considering the ongoing shortages of donor corneas, which have historically impeded millions of patients from accessing critical sight-restoration surgeries each year. In numerous countries, patients may only wait a few days for a transplant, while many others face agonizing delays of months or even years due to low donor availability. The capacity to generate multiple implants from a single donor cornea addresses this significant issue head-on, offering renewed hope to individuals long hindered by vision impairment.

The surgery that proved it works

The groundbreaking surgery was performed under the guidance of Professor Michael Mimouni, the director of the Cornea Unit in the Department of Ophthalmology at Rambam Eye Institute. Describing the moment as unforgettable, he articulated the profound satisfaction of being able to restore sight to a real patient for the first time using a lab-grown implant. He stated,

“What this platform shows and proves is that in the lab, you can expand human cells. Then print them on any layer you need, and that tissue will be sustainable and work. We can hopefully reduce waiting times for all kinds of patients waiting for all kinds of transplants.”

This surgical procedure is an integral part of an ongoing Phase 1 clinical trial focused on evaluating safety and tolerability among patients suffering from corneal endothelial disease. This accomplishment is the result of years of collaborative efforts across various research laboratories, operating rooms, and corporate partnerships. It demonstrates how effective teamwork can transition innovative scientific concepts into viable clinical practices.

How the science fits into a bigger future

The implications of this advancement will find a permanent home in Rambam’s forthcoming Helmsley Health Discovery Tower, an establishment intending to consolidate healthcare, training, and research into a unified facility. This initiative aims to accelerate the translation of cutting-edge scientific discoveries into practical treatments for patients in Northern Israel and beyond.

Furthermore, according to Precise Bio, the same 3D printing technologies being utilized for corneal implants could eventually support the development of other vital tissues, including cardiac muscle, liver, and kidney cells. While these ambitious plans will necessitate extensive trials and validation, the successful corneal implant serves as a promising stepping stone toward a future of achievable tissue regeneration.

What this means for you

For families dealing with corneal disease, this breakthrough instills immense hope. While donor tissue will likely continue to play a role in many geographic areas, the emergence of lab-grown implants provides a pivotal strategy to broaden access to sight-saving treatments in regions burdened by donor shortages. The success of this initial transplant not only brings renewed optimism for individuals facing debilitating vision issues but also paves the way for a future in regenerative medicine, opening doors for numerous types of tissue repair.

This milestone also highlights the protracted timeline of scientific achievements before they reach actual patients. The very first 3D-printed corneal design was introduced in 2018, and it has taken until now for the technology to transition into human applications. Nevertheless, progress appears swift and tangible when measured against the life-altering results of restored eyesight.

Key takeaways and future implications

This successful transplantation marks a pivotal moment in the field of eye care, suggesting a future where the limitations imposed by donor supply no longer dictate who can benefit from sight-restoring surgery. As further trial results emerge, it will become increasingly clear how scalable this technology is and which patient demographics stand to gain the most from these advancements.

The news raises an important question: If regenerative implants become mainstream, what medical challenges should researchers prioritize next? This curiosity encourages public dialogue around future developments in the field.

Summary

The successful transplantation of a lab-grown corneal implant represents a transformative breakthrough in ophthalmology, providing hope for patients suffering from vision impairment due to corneal disease. This achievement not only alleviates the burdens associated with donor shortages but also points toward a future enriched by advancements in regenerative medicine, demonstrating the potential for wider application across various medical fields.

Frequently Asked Questions

Question: What is a corneal implant?

A corneal implant is a medical device designed to replace damaged or diseased corneal tissue in the eye, restoring vision.

Question: How are 3D printed corneas made?

3D printed corneas are created using cultured human corneal cells that are layered and printed to mimic natural corneal structure.

Question: What are the future implications of this technology?

The technology could pave the way for the development of other vital tissues, such as cardiac muscle or liver cells, potentially transforming various aspects of medical treatment.

©2025 News Journos. All rights reserved.

A groundbreaking development in neurotechnology took place recently when Paradromics successfully implanted its brain-computer interface (BCI) in a human during a routine epilepsy surgery at the University of Michigan. This procedure marks a significant milestone for the neurotech company, which has been striving to harness the power of brain implants for nearly a decade. With this significant achievement, Paradromics is making strides toward the clinical testing phase, aiming to evaluate the long-term efficacy and safety of its innovative device.

Understanding Brain-Computer Interfaces

A brain-computer interface (BCI) is an innovative technology designed to facilitate direct communication between the human brain and external devices. Typically, these devices are employed to help individuals with severe motor disabilities communicate or regain functionality. Paradromics has developed a particular version, known as Connexus, which is specially designed to interpret brain signals and convert them into commands for various digital devices. This capability is especially significant for individuals with conditions such as paralysis, where traditional forms of communication may be unavailable.

The recent human trial conducted by Paradromics confirmed that their BCI functions effectively in processing neural activity. During a brief 20-minute surgical procedure, the team successfully implanted the device in a patient undergoing an epilepsy operation. This accomplishment lays the foundation for wider use of BCIs, moving them from experimental phases to potential mainstream clinical applications.

The Connexus Device: Features and Functionality

The Connexus BCI is notable because of its advanced engineering and extensive capabilities. One of the standout features is its integrated 421 microelectrodes, which are significantly smaller than human hair. These electrodes allow the device to gather data from individual brain cells with a remarkable level of accuracy. The materials used for the device, such as titanium and platinum-iridium, are well-established in the medical field for their compatibility with human tissue, crucial for long-term implantation.

Data captured by the microelectrodes is transmitted to a chest-mounted device that wirelessly communicates with computers and other digital tools. Facilitated by sophisticated artificial intelligence programming, the BCI can interpret mental commands, translating thoughts into spoken words, text, or other digital inputs. This offers a new realm of interaction for individuals with debilitating conditions, potentially transforming their capacity for communication and interaction with technology.

The Process of Implantation and Data Transmission

The implantation of the Connexus BCI involves a series of coordinated steps intended to maximize effectiveness while minimizing risk. Initially, the device is securely placed under the skin, employing established surgical techniques. Once implanted, the small electrodes commence their task of detecting signals from individual neurons located in the motor cortex, the area responsible for movement control.

These neural signals are then conveyed through thin wires to a compact device located in the patient’s chest. This device plays a critical role in wirelessly transmitting collected data to external systems, enabling seamless interaction with computers or mobile devices. Advanced algorithms assess the transmitted data and accurately decode the user’s intended actions or expressions, facilitating a natural flow of communication for those often unable to verbalize their thoughts.

The Team Behind the Breakthrough

The pivotal procedure was spearheaded by Dr. Oren Sagher, a professor of neurosurgery, alongside Dr. Matthew Willsey, an assistant professor of neurosurgery and biomedical engineering, at the University of Michigan. Their collective expertise, enriched by a diverse team of neurologists and engineers, ensured that the implantation was executed safely and effectively. Dr. Willsey highlighted that the Paradromics device outperformed previous models, featuring over four times the sensor density, thereby providing more intricate and detailed monitoring of brain activity.

Future Directions for Neurotechnology

Paradromics is not operating in isolation within the realm of neurotechnology; other prominent companies like Neuralink, Synchron, and Precision Neuroscience are also engaged in developing competing brain-computer interfaces. Each entity approaches the technology from different angles, but Paradromics is particularly focused on recording data from individual brain cells. This strategy could radically enhance how communication occurs for patients with severe neural impairments.

Having recently secured close to $100 million in funding and partnerships, Paradromics enjoys a favorable position in the industry landscape. Additionally, the company is part of a special FDA program designed to expedite the development of transformative medical technologies. With clinical trials aimed at individuals suffering from conditions such as ALS or spinal cord injuries on the horizon, the future holds great promise for the potential of BCIs to provide fundamental improvements in communication abilities and quality of life.

Summary

The successful implantation of Paradromics’ brain-computer interface is a pivotal advancement in neurotechnology that could greatly aid individuals with severe movement disorders. By bridging the gap between thought and action, BCIs offer new avenues for communication and independence for countless individuals facing debilitating challenges. As Paradromics continues to push the boundaries of this technology, it represents a major step toward enhancing the quality of life for many, subsequently reshaping the landscape of medical innovation.

Frequently Asked Questions

Question: What is a brain-computer interface (BCI)?

A brain-computer interface (BCI) is a technology that enables direct communication between the brain and external devices, facilitating control of computers or other technologies through thought.

Question: How does Paradromics’ Connexus BCI work?

The Connexus BCI captures neural activity through microelectrodes, which transmit data wirelessly to external devices where advanced algorithms decode the signals into speech or actions.

Question: What conditions could benefit from advancements in BCI technology?

Individuals suffering from severe motor impairments such as ALS, stroke, or spinal cord injuries could potentially benefit from BCIs, allowing them to communicate more effectively and regain some level of independence.

©2025 News Journos. All rights reserved.

A remarkable technological breakthrough is allowing patients with ALS to communicate using their thoughts, as demonstrated by the journey of Brad G. Smith. Diagnosed with this debilitating disease, Smith found a new form of expression through a Neuralink brain implant. This revolutionary device not only enhances his ability to communicate but also potentially paves the way for advancements in assistive technology for others facing similar challenges.

Life before Neuralink

Before the advent of the Neuralink implant, Brad G. Smith faced significant barriers in communication due to the progression of his ALS. This condition severely affects the nerves controlling voluntary muscle movements, leading to a gradual loss of his ability to speak and move. For years, he relied on eye-tracking technology that, despite its innovation, presented numerous challenges.

“It is a miracle of technology, but it is frustrating. It works best in dark rooms, so I was basically Batman. I was stuck in a dark room,”

Smith explained in a recent post on social media.

The eye-tracking device functioned well under dim lighting but faltered in brighter environments, leading to slow and often frustrating communication attempts. The limitations of the technology not only hindered his interactions with loved ones but also affected his emotional well-being. After receiving the Neuralink implant, however, Smith expressed newfound joy in being able to communicate freely, stating,

“Neuralink lets me go outside and ignore lighting changes.”

How the Neuralink brain implant works

The Neuralink device that Smith received is a sophisticated Brain-Computer Interface (BCI), making him the first non-verbal person and only the third person worldwide to utilize this technology. The implant, about the thickness of five stacked coins, resides in his skull and connects to the motor cortex—the area responsible for movement. It contains tiny wires, smaller than human hair, that penetrate into Smith’s brain.

These microscopic wires capture neural signals and transmit them wirelessly to a connected device, decoding Smith’s thoughts into actions on a computer. The implant has 1,024 electrodes that capture neuron firings every 15 milliseconds, producing a wealth of information for the system to analyze. Smith described how the implant operates, stating,

“Neuralink does not read my deepest thoughts or words I think about. It just reads how I wanna move and moves the cursor where I want.”

This rapid decoding of brain signals allows Smith to move a cursor across a screen using only his thoughts, dramatically enhancing his ability to communicate and interact online. The technology has immense potential, particularly for individuals with similar conditions affecting their ability to communicate.

Training the brain-computer connection

Adjusting to the Neuralink implant required a period of trial and error. Initially, attempts to map Smith’s hand movements to cursor movements were not effective. However, further research indicated that the signals associated with tongue movements proved to be more reliable for navigating the cursor. Additionally, clenching his jaw became the mechanism for executing clicks on the screen.

Smith elaborated on how this technique evolved, saying,

“I am not actively thinking about my tongue, just like you don’t think about your wrist when you move a mouse. I think my brain has switched over to subconscious control quickly.”

By enabling this connection, Smith has begun to use the technology more naturally, transitioning cursor movement into a subconscious task.

Everyday life: Communication, play, and problem-solving

The benefits of the Neuralink implant extend far beyond mere communication; it has provided Smith with the ability to engage in daily activities that many take for granted. He can now interact with his family through video games like Mario Kart, bringing a sense of normalcy to family life. The system includes a virtual keyboard, along with shortcuts for tasks like copying and pasting, significantly streamlining his online navigation.

Smith collaborated with Neuralink engineers to create features that cater to his unique needs. One such feature he developed is a “parking spot” for the cursor, allowing him to set it aside while he watches videos or takes breaks. He noted,

“When it is in the parking spot, I can watch a show or take a nap without worrying about the cursor.”

The human side: Family, faith, and perspective

While technological advancement has transformed Smith’s ability to communicate, his journey has also been profoundly influenced by personal factors. Smith attributes his resilience to the unwavering support of his wife, Tiffany, calling her the “best caregiver I could ever imagine.” He acknowledges the role of family, friends, and faith in navigating the daily challenges presented by ALS.

Despite the hardships associated with the disease, Smith finds solace in his faith, expressing that he has gained a deeper understanding of his journey. He mentioned,

“I have not always understood why God afflicted me with ALS but with time I am learning to trust his plan for me.”

Smith believes that these experiences have not only strengthened his character but also brought him closer to his family and his faith.

Summary

The journey of Brad G. Smith highlights the intersection of technology and humanity in addressing the needs of individuals with severe communication impairments caused by ALS. The Neuralink brain implant has not only restored Smith’s ability to express himself but has also introduced a new dimension of gaming and interaction with his family. As research and technology continue to advance, there is hope for further breakthroughs that can improve the quality of life for many others facing similar challenges.

Frequently Asked Questions

Question: What is the Neuralink brain implant?

The Neuralink brain implant is a device that allows individuals to control a computer or communication device using their thoughts.

Question: How does the implant help individuals with ALS?

The implant enables individuals with ALS to communicate more effectively by decoding brain signals into actions on a computer screen, overcoming the limitations of previous technologies.

Question: What impact does this technology have on everyday life?

The technology significantly enhances daily interactions, allowing users to engage in activities like gaming and social communication that may have been difficult due to physical limitations.

©2025 News Journos. All rights reserved.

Seventeen-year-old Clara Fuller has experienced a life-altering transformation after undergoing a cutting-edge brain implant procedure designed to treat her severe epilepsy. For years, Clara endured nightly seizures, often up to ten, which disrupted her life and affected her ability to enjoy typical teenage activities. The innovative use of the NeuroOne implant technology at the Mayo Clinic has provided hope for those with drug-resistant epilepsy, demonstrating significant improvements in quality of life through advanced medical treatments.

A life turned upside down

At just 13 years old, Clara began experiencing uncontrollable seizures that left both her and her doctors bewildered. Initially misdiagnosed with anxiety issues and gallbladder problems, Clara underwent unnecessary surgery before her true condition was discovered: multifocal epilepsy. This rare and severe form of epilepsy proved resistant to all medicinal treatments available, leading to extreme physical and emotional tolls on her life.

“Every night I would have seizures, up to 10, and it was just miserable,” Clara reflected, highlighting the isolation and challenges she faced as a young teenager grappling with such a debilitating condition. Her adolescence was characterized by sleepless nights, diminished social interactions, and an all-consuming battle with her health that overshadowed typical teenage experiences.

Despite numerous treatments and consultations over the years, Clara found herself trapped in a cycle of ineffective therapies. The initial misdiagnoses meant valuable time was lost, and as her seizures persisted, it appeared that traditional medical options were dwindling, leaving her family desperate for a solution.

A revolutionary solution

The breakthrough came during the summer of 2025 when Clara made history as the first pediatric patient to receive the NeuroOne brain implant at the Mayo Clinic. Utilizing the NeuroOne OneRF Ablation System, which recently received FDA clearance, the procedure involved both diagnosing and treating Clara’s epilepsy in one minimally invasive operation.

“It took them maybe 30 minutes, and the longest part was setting up,”

Clara said, expressing her amazement at how swiftly the groundbreaking procedure transformed her life. Dr. Brin Freund, a neurologist involved in her case, elaborated on the necessity of the innovative approach:

“Clara’s history of seizures was uncontrolled with medications. In such cases, surgery may be the only option to reduce and potentially cure the seizure disorder,” Dr. Freund explained. After careful evaluation, the medical team recommended the implementation of engineers for a precise understanding of seizure origins in Clara’s brain, laying the groundwork for effective intervention.

Clara and her family agreed to the plan due to her condition’s severity, which drove them to seek pioneering medical options after conventional methods failed. The NeuroOne electrodes were implanted to monitor seizure activity and assess targeted treatment possibilities.

How NeuroOne’s dual-function system works

The innovative NeuroOne system operates through ultra-thin electrodes designed to accurately identify the origins of seizures within the brain. Once the problem areas are localized, radiofrequency energy is applied to disrupt abnormal electrical patterns without causing permanent damage to surrounding healthy tissue. This integrated approach, combining diagnostics and therapy in a single surgery, sets NeuroOne apart from traditional epilepsy treatments, which typically require separate interventions.

As NeuroOne CEO Dave Rosa noted,

“What separates our technology from others is that our device can be used for both the diagnostic part – finding the area of the brain – and then ablating or destroying that tissue, all in the same hospitalization.”

This dual-function model minimizes patient risk by decreasing the number of required surgical procedures. Dr. Freund highlighted the effectiveness of the stereo EEG electrodes, emphasizing their capability to localize seizure onset with precision while allowing for concurrent treatments.

“We can record seizure data, perform the ablation, and then verify treatment success by monitoring activity,” he stated, underscoring the remarkable potential of this technology in crafting tailored treatments for epilepsy.

The results

The outcome of Clara’s procedure has been nothing short of miraculous. Since receiving the NeuroOne implant and subsequent treatments, she has enjoyed a seizure-free life. This newfound stability has allowed Clara to return to everyday activities, including school and sports, restoring a sense of normality she thought was irretrievably lost during years of suffering.

Dr. Freund confirmed Clara’s progress, stating,

“Regarding the implantation itself, she did very well, and there were no adverse effects. We performed a second ablation a few days later, monitoring the data to prevent ongoing seizures. This was also well tolerated without complications. Since the ablation, Clara has remained seizure-free and has thrived.”

Clara’s journey offers hope to the one-third of the 3 million Americans living with epilepsy, particularly those struggling with drug-resistant forms. As recognized by CEO Rosa, the goal is to expand ablation therapy to these patients to enhance their quality of life.

A broader impact on medicine

The implications of NeuroOne’s technology extend beyond epilepsy treatment. Plans are underway to explore applications in pain management for conditions such as facial and lower back pain, utilizing the same radiofrequency ablation technology. Rosa identified pain management as a significant arena ripe for future advancements.

Dr. Freund echoed this sentiment, suggesting that the development could considerably improve long-term care for pediatric epilepsy patients like Clara. He stated,

“This technology could limit the number of procedures needed to manage drug-resistant focal epilepsy and provide immediate feedback on surgical efficacy.”

He further noted that the ability to access deeper parts of the brain could facilitate safer and more effective surgical options for patients. As expertise with these electrodes increases within medical centers, their use will likely become even more widespread, leading to enhanced surgical outcomes for those affected by neurological disorders.

Summary

The story of Clara Fuller illustrates the significant advancements in neurology made possible through innovative technologies like the NeuroOne brain implant system. By addressing severe, drug-resistant epilepsy with a pioneering treatment approach, Clara has regained control over her life and displays a hopeful future for others facing similar conditions. This evolution in medical technology not only provides immediate benefits for individuals but also sets the groundwork for broader applications in managing neurological disorders.

Frequently Asked Questions

Question: What is multifocal epilepsy?

Multifocal epilepsy is a form of epilepsy characterized by seizures originating from multiple areas of the brain, often resistant to standard treatments.

Question: How does NeuroOne’s implant work?

The NeuroOne implant uses ultra-thin electrodes to locate seizure sources and employs radiofrequency energy to disrupt abnormal brain signals, combining diagnosis and therapy in one procedure.

Question: Can the NeuroOne technology be used for conditions other than epilepsy?

Yes, the NeuroOne technology is being explored for applications in pain management and may be expanded to treat other neurological conditions.

©2025 News Journos. All rights reserved.